BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. DRD2, T cell differentiation, HIV infection, Embryo, Pharmacogenetics, Fenofibrate)
Bookmark Forward

QuickView for regulation of mammary gland epithelial cell proliferation (biogroup)


Body Atlas

Most Correlated Tissues

  1. Globus pallidum external
  2. Hypothalamus
  3. Substantia nigra reticulata
  4. Temporal lobe
  5. Occipital lobe
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Alpha-1-antitrypsin deficiency
  2. Herpes simplex type 2 infection
  3. Disorder of digestive system
  4. Pyloric ulcer
  5. Injury of eye region
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. foretinib
  2. CYT 387
  3. brivanib alaninate
  4. ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)
  5. CGP 60474
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. LAT
  2. POLH
  3. NR5A1
  4. CA12
  5. TBC1D23
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP - Melanoma A375 cells with CRISPR-targeted gene knockouts
  2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
  3. The Cancer Genome Atlas (TCGA) - gene expression in glioblastoma multiforme
  4. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
  5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
Explore Curated Studies Results

Literature

Most Relevant Literature

There were no matches for regulation of mammary gland epithelial cell proliferation
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. CD133 Expression in Mammary Invasive Ductal Carcinoma
  2. Novel Biomarkers in Inflammatory Bowel Disease
  3. Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.